In conclusion, in vivo and in vitro studies demonstrate that E2 inhibits the actions of PPARα on obesity through its effects on hepatic PPARα -dependent regulation of target genes and that these processes are mediated by inhibition of PPARα recruitment of coactivators by E2-activated ERs (Figure 7). Here, PPARA is linked to obesity disorder.